One year in review
One year in review 2021: systemic vasculitis
F. Ferro1, L. Quartuccio2, S. Monti3, P. Delvino4, F. Di Cianni5, S. Fonzetti6, G. La Rocca7, C. Posarelli8, E. Treppo9, R. Talarico10, C. Baldini11
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. francescoferrodoc@gmail.com
- Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy.
- Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
- Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Ophthalmology Unit, Department of Surgical, Medical, Molecular Pathology and Emergency, University of Pisa, Italy.
- Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
CER14754
2021 Vol.39, N°2 ,Suppl.129
PI 0003, PF 0012
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 34014159 [PubMed]
Received: 25/04/2021
Accepted : 04/05/2021
In Press: 19/05/2021
Published: 19/05/2021
Abstract
Large- and small-vessel vasculitis are complex potentially life-threatening systemic autoimmune diseases that have recently been subjected to considerable immunologic and clinical research. Following the other reviews of this series, here we aim to summarise some of the most significant studies that have been recently published on the pathogenesis, clinical features and novel treatments of systemic vasculitis.
